Definitive Contract 75F40122C00154
Award Date
9/27/22
Potential Completion Date
9/27/25
Potential Value
$2.7M
Federal Agency
Food and Drug Administration
Awardee
Brigham & Womens Hospital Inc.
Ultimate Awardee
Partners Healthcare System Incorporated
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
165
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $2,082,291.00 firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, Massachusetts. The contract is for "Effectiveness Research with Real World Data to Support FDA's Regulatory Decision Making." It does not have a set-aside designation. Under the contract, Brigham & Women's Hospital is working closely with the FDA's...
The Food and Drug Administration (FDA) awarded a $4,691,150.00 firm fixed price contract to Brigham & Women's Hospital Inc. to conduct research on calibrating real-world evidence (RWE) studies in oncology against randomized clinical trials. The contract has a completion date of January 29, 2027 and does not have a small business set-aside designation. Brigham & Women's Hospital is a subsidiary of the larger Partners Healthcare System Incorporated, which is a major integrated healthcare...
The Department of Health and Human Services Food and Drug Administration awarded a $2,963,836.42 firm fixed price delivery order contract to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The contract supports developing capability to use Medicaid data for FDA post-market drug safety surveillance during pregnancy. This contract is a task order under the FDA's Scientific Pharmacoepidemiologic Research Program, a larger...
This federal contract award, valued at $13,290.62, was issued by the U.S. Food and Drug Administration (FDA) to Brigham & Women's Hospital Inc., a prominent academic medical center and research institution affiliated with Harvard Medical School. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. The contract provides for research and development services at FDA facilities. Brigham & Women's Hospital Inc. is a subsidiary of the larger Partners Healthcare...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price contract to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The $120,000 contract is for services in support of a project entitled "Confidence in Decision-Making: Evaluating a Structured Reporting Template to Increase Transparency and Reduce Review Time for Healthcare Database Studies." The contract has a completion date...
This is a task order awarded to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, by the Food and Drug Administration. The $91,189.41 firm-fixed-price task order is for support in providing communications expertise and planning annual meetings related to the agency's epidemiology initiatives. The award is not set aside for small businesses. Brigham & Women's Hospital Inc. has extensive experience providing specialized medical research and...
This is a $6,914,101.00 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) on January 19, 2024. The primary objective is to make rich clinical information encoded by billions of real-world laboratory test results available to the public in an effortless yet HIPAA-compliant manner, to advance regulatory science. This contract is not set-aside and has a period of performance through January 18, 2027. Bidmc is...
This is a $978,324 definitive contract awarded by the Food and Drug Administration (FDA) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for a 2-year period ending in April 2025. The contract is to enhance the FDA's Source Model by incorporating and analyzing state and regional-level data. The contract was awarded under a Broad Agency Announcement (BAA) that solicits advanced research and development proposals to support FDA regulatory science...
This is a $1,734,285.97 definitive contract awarded by the U.S. government to Brigham & Women's Hospital Inc., a non-profit hospital and research institution based in Boston, Massachusetts. The contract is for "OTHER MEDICAL (APPLIED/EXPLORATORY)" services and does not have a set-aside designation. Brigham & Women's Hospital Inc. is a subsidiary of Partners Healthcare System Incorporated, which has supported the hospital's federally-funded biomedical research and specialized...
This is a $3,934,148 firm-fixed-price delivery order contract awarded by the Agency for Healthcare Research and Quality (AHRQ) to Brigham & Women's Hospital Inc., a major academic medical center and research institution in Boston, Massachusetts. The contract was awarded under the ARRA (American Recovery and Reinvestment Act) to support the development and strengthening of scientific methods for conducting comparative effectiveness research (CER). This delivery order is part of a larger...